Alere NMP22 BladderChek Bladder Cancer Test, CLIA Waived, Rapid, 24/Box
The Alere NMP22 BladderChek is a rapid, CLIA-waived in vitro diagnostic test for the qualitative detection of nuclear matrix protein 22 (NMP22) in urine, aiding in the monitoring and diagnosis of bladder cancer. This test provides results in a simple, point-of-care format, suitable for use in clinical laboratories and physician offices. Each box contains 24 individual test kits.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
The Alere NMP22 BladderChek is a rapid, CLIA-waived in vitro diagnostic test for the qualitative detection of nuclear matrix protein 22 (NMP22) in urine, aiding in the monitoring and diagnosis of bladder cancer. This test provides results in a simple, point-of-care format, suitable for use in clinical laboratories and physician offices. Each box contains 24 individual test kits.
1 vendor
